INSTITUTE

SCIENCE

PATIENT

Our branches

Branch in Gliwice

Branch in Krakow

Branch
in Gliwice

Branch
in Cracow

News


Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1596

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1760

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1596

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1760

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1596

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1760

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1596

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1760

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1596

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1760

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1596

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1760

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1596

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1760

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1596

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1760

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1596

Warning: Undefined variable $ar_template in /home/intervipl/domains/nio.intervi.pl/public_html/wp-content/plugins/fusion-builder/inc/class-fusion-template-builder.php on line 1760

From the laboratory table to the patient bed

National Institute of Oncology named after Maria Skłodowska-Curie – National Research Institute is the largest oncology facility in Europe combining scientific, research and clinical work.

The activities of the National Institute of Oncology are the process of a rapidly evolving discipline in the field of biomedical research, and its goal is to accelerate the discovery of new diagnostic tools and therapies through an interdisciplinary approach based on collaborative action.

Translational medicine, often described as the practice of transferring scientific knowledge “from the laboratory table to the patient’s bedside,” uses advances in basic research to develop new therapies and medical procedures.

The basis of our activity is the analysis of information obtained from many research sources. This process allows us to expand our understanding of human biology, expand our understanding of disease, and find, research and develop treatments faster. This approach results in more modern patient treatment and better outcomes.

We are open to international cooperation to develop the development of new therapies.

Comprehensive care in one place:

“The process of developing new therapies starts on the laboratory bench.

It is in the laboratory that we work on understanding the mechanisms of carcinogenesis, as well as on the mechanisms of the immune system’s fight against cancer. We strive to develop new therapies to help the largest number of patients.

Our research is conducted on many levels. We have to respond to new challenges, such as a pandemic, which is why we are developing a drug against covid-19 using the latest technologies.

In addition, we are working on the innovative CAR-T technology, as well as on the mechanisms of T lymphocyte depletion by cancer cells.

At the National Institute of Oncology, under the guidance of experienced scientists, young researchers have a chance to discover the secrets of the functioning of the human body at the Institute. It is hard to find another place where you can clearly see how scientific work translates directly into people’s lives.”

dr hab. n. med. Elżbieta Sarnowska, professor of the institute

“Thanks to translational research, which is one of the stages in the development of targeted therapies, we verify whether the results of basic analyzes have a clinical impact.

Only then do pharmaceutical companies start producing specific drugs.

Currently, genetic testing is a key step in qualifying patients for targeted therapies, as well as in the differentiation and classification of cancer.”

Dr. med. Andrzej Tysarowski

“Medicine is constantly evolving. Therapeutic options are sought for those oncological patients for whom standard treatment is not possible.

The patient has the opportunity to participate in clinical trials, which are conducted in the Department of Early Phases.

Trials are being piloted with drugs that modify the immune system and drugs targeted at a molecular target in a cancer cell.

Molecular diagnostics is carried out at the Center of Excellence in Precise Oncology, which closely cooperates with the Department of Early Phase Research, organ clinics at the institute, as well as other centers in the country.”

dr hab. n. med. Iwona Ługowska, professor at the institute

“The large number of patients treated at the Institute makes it possible to conduct clinical trials on new therapies.

The human body is extremely complex.

Therefore, in order to be able to fully assess the effectiveness and efficiency of new drugs, it is necessary to conduct large numbers of clinical trials.

The National Institute of Oncology in Warsaw conducts about 500 clinical trials annually.”

Prof. dr hab. med. Piotr Rutkowski

“In recent years, tremendous progress has been made in oncological treatment.

Thanks to this, we can approach each of our patients very individually.

This means that when choosing a treatment, we rely on the results of very complex molecular and genetic tests. At the Institute, we also cooperate with top-class specialists in the field of molecular biology, pathology and genetics.

It is now possible to tailor therapy to the results of molecular testing.”

Dr. med. Agnieszka Jagiello – Gruszfeld

“The National Institute of Oncology brings together many excellent specialists in various fields. Thanks to this, access to knowledge is really wide.

We are able to choose the optimal and most appropriate therapy, giving the patient the best chance of recovery.”

dr hab. n. med. Pawel Wiechno, professor of the institute

“Our mission begins in the laboratory, but ends in the most important place – at the patient’s bedside.

It is always about finding and proposing the best treatment plan – dedicated to our patient.”

Director of NIO-PIB prof. dr hab. n. med. Jan Walewski

Maria Sklodowska-Curie

Maria Sklodowska-Curie. Shelf. physicist. Chemist. Woman. Scientist.
Two-time Nobel Prize winner. Professor. Wife. Mother. Man. In the world, she is known mainly for the discovery of two elements – radium and polonium, and groundbreaking research on radioactivity.

For us – the founder and patron. Inspiration. Pride.

Marie Skłodowska-Curie is often portrayed as serious, withdrawn, dry and unattractive. However, the perception of Maria as a person devoid of feelings is just a stereotype. Her love of science went hand in hand with her love of life. Maria liked and impressed men: she spoke four languages, traveled, was able to find sponsors and infect them with her passion, commercialize her research to industry and engage in social activities – she was a volcano of energy and passion, and her friend – Albert Einstein remained under her spell for many years.